GNAS is mutationally activated in various cancer types, such as growth hormone-secreting pituitary tumors, pancreatic cancer and colorectal cancer, while has inactivating mutations in pseudohypoparathyroidism type 1a (11, 12). This evidence concerns the gene GH1 and colorectal cancer.